Presence Of Microplastics In Salt Sugar Brands NGT Issues Notice To Authorities

New Delhi: The National Green Tribunal has called on the Indian Council of Medical Research (ICMR) and the Food Safety and Standards Authority of India (FSSAI) to address the issue of microplastics found in all salt and sugar brands in the country.

The tribunal, acting on its own after a PTI report, noted that these microplastics appear as fibers, pellets, films, and fragments, with sizes ranging from 0.1 mm to 5 mm. The highest levels were found in iodised salt, particularly in the form of multicolored thin fiber and films.

In sugar, microplastic concentrations differed, peaking at 68.25 pieces per kg in non-organic samples. The tribunal underscored the potential long-term health risks posed by these contaminants, emphasizing the discrepancy between India’s consumption rates and WHO recommendations. Respondents were directed to file their responses by December 3, ensuring their attendance if filing directly.

Related Posts

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?